• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有非比例风险函数的生存数据分析。

Analysis of survival data with nonproportional hazard functions.

作者信息

Stablein D M, Carter W H, Novak J W

出版信息

Control Clin Trials. 1981 Jun;2(2):149-59. doi: 10.1016/0197-2456(81)90005-2.

DOI:10.1016/0197-2456(81)90005-2
PMID:7273792
Abstract

The log-rank test or the proportional hazard model is a valuable, widely accepted method for analyzing time-to-response data from comparative clinical trials. When the hazard ratio is constant in time, this procedure is optimal. Indiscriminate or unthinking use of this approach results in problems in the determination of treatment differences. For example, when the true survival curves intersect, the hazard ratio cannot be constant, i.e., the hazard functions are not proportional. It is shown that by considering time-by-treatment interactions we gain flexibility in describing the relationships among hazard functions. In this paper we demonstrate with the results of a clinical trial how available methodology can be used to permit tests for the appropriateness of the model and to enable informative analysis of such data.

摘要

对数秩检验或比例风险模型是一种有价值且被广泛接受的方法,用于分析来自比较临床试验的反应时间数据。当风险比在时间上恒定时,此方法是最优的。不加区分或盲目使用这种方法会在确定治疗差异时产生问题。例如,当真实生存曲线相交时,风险比不可能恒定,即风险函数不成比例。结果表明,通过考虑时间与治疗的交互作用,我们在描述风险函数之间的关系时获得了灵活性。在本文中,我们通过一项临床试验的结果证明了如何使用现有方法来检验模型的适用性,并对这类数据进行有意义的分析。

相似文献

1
Analysis of survival data with nonproportional hazard functions.具有非比例风险函数的生存数据分析。
Control Clin Trials. 1981 Jun;2(2):149-59. doi: 10.1016/0197-2456(81)90005-2.
2
A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.一种用于生存数据荟萃分析中评估治疗效果的非参数方法。
Stat Med. 2004 Apr 15;23(7):1075-93. doi: 10.1002/sim.1696.
3
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?平均风险比——当比例风险假设不成立时,用于事件发生时间终点的良好效应量度?
Methods Inf Med. 2018 May;57(3):89-100. doi: 10.3414/ME17-01-0058. Epub 2018 May 2.
4
Improving testing and description of treatment effect in clinical trials with survival outcomes.提高生存结局临床试验中的检测和治疗效果描述。
Stat Med. 2019 Feb 20;38(4):530-544. doi: 10.1002/sim.7676. Epub 2018 Apr 19.
5
Measuring Survival Benefit in Health Technology Assessment in the Presence of Nonproportional Hazards.存在非比例风险时健康技术评估中的生存获益测量。
Value Health. 2019 Apr;22(4):431-438. doi: 10.1016/j.jval.2019.01.005. Epub 2019 Mar 23.
6
Sample sizes based on the log-rank statistic in complex clinical trials.基于复杂临床试验中对数秩统计量的样本量。
Biometrics. 1988 Mar;44(1):229-41.
7
Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer.探索性数据分析以及使用风险函数解释生存数据:研究者入门指南。
J Clin Oncol. 1985 Oct;3(10):1418-31. doi: 10.1200/JCO.1985.3.10.1418.
8
The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio.在对数风险比的百分比误差错误设定模型下加权对数秩检验的效率。
Biometrics. 1992 Sep;48(3):893-9.
9
Partitioned log-rank tests for the overall homogeneity of hazard rate functions.用于风险率函数总体同质性的分割对数秩检验。
Lifetime Data Anal. 2017 Jul;23(3):400-425. doi: 10.1007/s10985-016-9365-0. Epub 2016 Mar 19.
10
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.在具有事件发生时间终点的优效性试验中,受限平均生存时间与风险比的比较。
Pharm Stat. 2018 May;17(3):202-213. doi: 10.1002/pst.1846. Epub 2017 Dec 28.

引用本文的文献

1
The type II exponentiated half logistic-odd Burr X-G power series class of distributions with applications.具有应用的II型指数化半逻辑奇数 Burr X-G幂级数分布类
Heliyon. 2023 Nov 17;9(11):e22402. doi: 10.1016/j.heliyon.2023.e22402. eCollection 2023 Nov.
2
Neural Survival Clustering: Non-parametric mixture of neural networks for survival clustering.神经生存聚类:用于生存聚类的神经网络非参数混合模型
Proc Mach Learn Res. 2022;174:92-102.
3
Inferences for Weibull Fréchet Distribution Using a Bayesian and Non-Bayesian Methods on Gastric Cancer Survival Times.
贝叶斯和非贝叶斯方法在胃癌生存时间中的威布尔-弗雷歇分布推断。
Comput Math Methods Med. 2021 May 26;2021:9965856. doi: 10.1155/2021/9965856. eCollection 2021.
4
Goodness-of-fit tests for the Compound Rayleigh distribution with application to real data.复合瑞利分布的拟合优度检验及其在实际数据中的应用。
Heliyon. 2019 Aug 28;5(8):e02225. doi: 10.1016/j.heliyon.2019.e02225. eCollection 2019 Aug.
5
Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint.汇总数据中比例风险假设的评估:使用生存时间终点的临床试验中统计方法的系统评价
Br J Cancer. 2018 Dec;119(12):1456-1463. doi: 10.1038/s41416-018-0302-8. Epub 2018 Nov 13.
6
EMPIRICAL LIKELIHOOD INFERENCE FOR THE COX MODEL WITH TIME-DEPENDENT COEFFICIENTS VIA LOCAL PARTIAL LIKELIHOOD.基于局部偏似然的具有时变系数的Cox模型的经验似然推断
Ann Stat. 2009 Sep 1;36(3):444-462. doi: 10.1111/j.1467-9469.2008.00634.x.
7
Checking the censored two-sample accelerated life model using integrated cumulative hazard difference.使用综合累积风险差异检验删失双样本加速寿命模型。
Lifetime Data Anal. 2007 Sep;13(3):371-80. doi: 10.1007/s10985-007-9039-z. Epub 2007 May 26.